33. Radionuclide Scintigraphy in Metabolic Bone Disease

  1. Clifford J. Rosen MD
  1. Gary J.R. Cook,
  2. Gopinath Gnanasegaran and
  3. Ignac Fogelman

Published Online: 19 JUL 2013

DOI: 10.1002/9781118453926.ch33

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Eighth Edition

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Eighth Edition

How to Cite

Cook, G. J.R., Gnanasegaran, G. and Fogelman, I. (2013) Radionuclide Scintigraphy in Metabolic Bone Disease, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Eighth Edition (ed C. J. Rosen), John Wiley & Sons, Inc., Ames, USA. doi: 10.1002/9781118453926.ch33

Publication History

  1. Published Online: 19 JUL 2013
  2. Published Print: 19 AUG 2013

ISBN Information

Print ISBN: 9781118453889

Online ISBN: 9781118453926

SEARCH

Keywords:

  • metabolic bone diseases;
  • radionuclide scintigraphy;
  • single photon emission computed tomography (SPECT)

Summary

Radionuclide bone imaging remains the most widely used method for detection of benign and metastatic involvement of the skeleton. This chapter talks about the applications of radionuclide scintigraphy in bone metastases, osteoporosis, Paget's disease, hyperparathyroidism, renal osteodystrophy, and osteomalacia. Recent advances in hybrid anatomical/functional imaging consolidates the roles of radioisotope imaging in skeletal disease. In particular, hybrid single photon emission computed tomography (SPECT)/CT provides an opportunity to more accurately assess specific clinical problems, such as persistent back pain in osteoporotic patients.